Sign inGet started

Michor Franziska

Insider CIK 2045159 · RXRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RXRX RECURSION PHARMACEUTICALS, A Award2026-06-172026-06-2288,424— $0215,477SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2025-06-182025-06-2344,031— $044,031SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2025-06-182025-06-2322,016— $0127,053SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2024-11-202024-11-2215,286— $015,286SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2024-11-202024-11-2230,670— $030,670SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2024-11-202024-11-2282,781— $082,781SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2024-11-202024-11-2217,694— $017,694SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2024-11-202024-11-2241,390— $0105,037SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2024-11-202024-11-2217,694— $063,647SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2024-11-202024-11-2215,335— $045,953SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2024-11-202024-11-2230,618— $030,618SEC↗